<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d1 20130915//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d1">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Biomedical Research and Therapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2198-4093</issn>
      <publisher>
        <publisher-name>BioMedPress</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.15419/bmrat.v5i1.405</article-id>
      <article-categories>
        <subj-group subj-group-type="display-channel">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Biomedical Research and Therapy</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Assessment of siRNA as a therapeutic molecule in Transient Receptor Potential Channel 5 gene silencing: a computational approach</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vijayaraghavan</surname>
            <given-names>Bhooma</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Padmanabhan</surname>
            <given-names>Giri</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ramanathan</surname>
            <given-names>Kumaresan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <aff id="aff1">
          <institution>Kidney Care, C50, 10TH B Cross, Thillai Nagar, Trichy</institution>
        </aff>
        <aff id="aff2">
          <institution>Department of Biochemistry, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University (Ayder Campus), Mekelle, Ethiopia</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>For correspondence: <email>kumaresan.ramanathas@mu.edu.et</email></corresp>
        <fn fn-type="con" id="equal-contrib">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>18</day>
        <month>1</month>
        <year>2018</year>
      </pub-date>
      <volume>5</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>9</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>12</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>12</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#169; The Author(s) 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/CC-BY/4.0">
          <license-p>This article is published with open access by BioMedPress (BMP), Laboratory of Stem Cell Research and Application, Vietnam National University, Ho Chi Minh city, Vietnam This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="http://www.bmrat.org/index.php/BMRAT/article/view/405/807"/>
      <abstract>
        <p>Background: Ion channels play a crucial role in Glomerular filter damage that contributes to albuminuria. Transient receptor potential channel 5 (TRPC5) gene mediating such damage, demand for its target specific inhibition by RNA interference mechanism. Designing and selecting potential siRNA for TRPC5 gene silencing by computational analysis. Materials &amp; Methods: The mRNA sequence was retrieved from NCBI (National Center for Biotechnology Information). siRNA sequences were designed specifically from target genes using InvivoGen siRNA wizard software. Thermodynamic RNA-RNA interactions were used to evaluate the gene silencing efficiency by minimum free energy of hybridization; the hybridization structures were also obtained using BIBISERV2-RNAHybrid. Results: The minimum free energy of hybridization of the three designed siRNAs (siRNA1, siRNA2 and siRNA3) were as follows: -28.2 kcal/mol, -24.1 kcal/mol, and-25.6 kcal/mol. Their corresponding GC content were 47.62%, 52.38% and 47.62%, respectively. Thus, siRNA1 had the least minimum free energy of hybridization (i.e. -28.2 kcal/mol) with low GC content (47.62%), and high linearity with minimal h-b index and loop structure. Conclusion: RNAi therapy can provide a new platform for efficient and targeted therapeutics. Further in vivo investigations are necessary to further validate their efficacy.</p>
      </abstract>
      <kwd-group>
        <kwd>Albuminuria</kwd>
        <kwd>gene silencing</kwd>
        <kwd>RNAi</kwd>
        <kwd>siRNA</kwd>
        <kwd>TRPC5</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Albuminuria is a major cause of morbidity and mortality in patients with chronic kidney diseases (CKD). It is a well-known condition that contributes to cardiovascular disease, poor renal outcome, diabetes, hypertension and kidney failure <xref ref-type="bibr" rid="ref19">Mogensen, 1984</xref><xref ref-type="bibr" rid="ref4">Berrut et al., 1997</xref><xref ref-type="bibr" rid="ref15">Keane et al., 2003</xref><xref ref-type="bibr" rid="ref2">Anavekar et al., 2004</xref><xref ref-type="bibr" rid="ref11">Gerstein et al., 2001</xref>. One of the key causes of albuminuria is malfunction of the glomerular filter which is crucial in sorting and preventing essential molecules from spilling into urine. Currently, there are no targeted therapies for the efficient protection of filter barrier function. The human kidney filter handles 180L of plasma each day. Therefore, an intact kidney filter is essential for retention of essential proteins in blood and removal of waste from the body <xref ref-type="bibr" rid="ref13">Haraldsson, 2008</xref><xref ref-type="bibr" rid="ref9">Farquhar, 2006</xref>.</p>
      <p>Ion channels play a predominant role in regulation of kidney filter function. Transient receptor potential (TRP) channels are greatly conserved nonselective cationic channels first documented in Drosophila, that has 6 members forming either homomeric or heteromeric tetramer <xref ref-type="bibr" rid="ref20">Montell, 2005</xref><xref ref-type="bibr" rid="ref21">Ramsey et al., 2006</xref>. Since these channels are greatly expressed in brain and kidney, their loss has the ability to cause fear response in mice <xref ref-type="bibr" rid="ref24">Riccio et al., 2009</xref>. Transient receptor potential channel 5 (TRPC5) functions as a cellular sensor of redox changes with inference for inflammation <xref ref-type="bibr" rid="ref30">Xu et al., 2008</xref>. Calcium (Ca2+) influx through homomeric TRPC5 channels alter the Rho family GTPase Rac1 to interrupt the integrity of the actin cytoskeleton in mesenchymal cells, such as fibroblasts and podocytes, at the cellular level resulting in filtration barrier damage. Therefore, Rac signaling can direct albuminuria in mice <xref ref-type="bibr" rid="ref27">Tian et al., 2010</xref><xref ref-type="bibr" rid="ref10">Faul et al., 2008</xref><xref ref-type="bibr" rid="ref16">Ma et al., 2010, Yanagida-Asanuma et al., 2007</xref><xref ref-type="bibr" rid="ref28">Togawa et al., 1999</xref>. TRPC5 intercedes damage to the filtration barrier, contributing to albuminuria which serves as an indicator for cardiovascular, metabolic and chronic kidney diseases. Hence, inhibition of the TRPC5 gene is a specific approach to protect glomerular filter damage and albuminuria <xref ref-type="bibr" rid="ref26">Thomas schaldecker et al., 2013</xref>.</p>
      <p>RNA interference (RNAi) is an evolutionary conserved mechanism of gene regulation process that needs double stranded RNA processed into small interfering RNA (siRNA) and micro RNA (miRNA) to suppress the expression of target genes (i.e. mRNA) in a sequence specific manner <xref ref-type="bibr" rid="ref29">Tuschl and Borkhardt, 2002, Ma et al., 2007</xref>. An siRNA is a double stranded RNA molecule typically having 19-21 nucleotide base pairs, that mediate its binding with target mRNA and promotes its degradation. The degradation prevents the translation of the mRNA, thus repressing the activity of the targeted mRNA <xref ref-type="bibr" rid="ref8">Elbashir et al., 2001</xref><xref ref-type="bibr" rid="ref32">Zamore et al., 2000</xref>. siRNA can be chemically synthesized and delivered into the cells by direct transfection, using nanoparticles or plasmid/viral vectors (Sayda et al., 2001; <xref ref-type="bibr" rid="ref6">Brummelkamp et al., 2002</xref>). Once the siRNA enters the cells, it gets cleaved by dicer (RNase III-like enzyme) and gets integrated into RNA-induced silencing complex (RISC) where the sense (passenger) stranded is degraded within RISC, while the anti-sense strands proceeds for post-transcriptional gene silencing process <xref ref-type="bibr" rid="ref14">Jackson et al., 2010</xref>. The degradation process is an extremely complicated one that consists of multiple steps including the initial binding of siRNA to RISC, followed by its activation which leads to mRNA recognition and degradation by using different exo- and endo- nucleases <xref ref-type="bibr" rid="ref3">Bernstein et al., 2001</xref><xref ref-type="bibr" rid="ref12">Hammond et al., 2000</xref>. The aim of this study is to inhibit TRPC5 gene in a target specific approach by designing effective siRNA molecules in context of RNAi mechanism.</p>
    </sec>
    <sec id="s2">
      <title>Materials - Methods</title>
      <sec id="s2-1">
        <title>Retrieval of TRPC5 gene (mRNA) sequence</title>
        <p>The mRNA sequence of the TRPC5 gene was retrieved from the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/). The Accession number of TRPC5 mRNA coding sequence was NM_012471.2. The sequence was retrieved in FASTA format and used for designing sequence specific siRNA molecules.</p>
      </sec>
      <sec id="s2-2">
        <title>Design of Potential siRNA molecules</title>
        <p>Target recognition was designed for the target TRPC5 mRNA using an online bioinformatic tool called InvivoGen siRNA wizard (http://www.invivogen.com/sirnawizard/design.php). This tool utilizes definite parameters such as siRNA motif size (21 nucleotides) and mRNA database (for human). siRNA sequences containing a palindrome are excluded to avoid unwanted hairpin structures. siRNA duplex with low GC content ranging from 30-55% are selected. The tool employs blast search to reduce off-target similarity.</p>
      </sec>
      <sec id="s2-3">
        <title>Multiple sequence alignment of designed siRNA molecules</title>
        <p>To analyze the sequence similarity and evolutionary relationship between designed siRNA molecules, multiple sequence alignment was conducted using ClustalW tool  (http://www.ebi.ac.uk/Tools/msa/; http://www.clustal.org/) according to standard parameters. Phylogenetic tree was constructed using clustal tree format, kimura&#8217;s distance correction and UPGMA (unweighted pair group method with arithmetic mean) method. Percentage identity matrix was also calculated.</p>
      </sec>
      <sec id="s2-4">
        <title>Calculation of GC content</title>
        <p>The GC content of the designed siRNA molecules was calculated using online GC calculator (http://www.endmemo.com/bio/gc.php). Any siRNA duplex with low GC content ranging from 40-55% was selected for further screening.</p>
      </sec>
      <sec id="s2-5">
        <title>The GC content was calculated using the following formula:</title>
        <p>(Number of G nucleotide + Number of C nucleotide)/Total number of nucleotide X 100 = GC content %</p>
      </sec>
      <sec id="s2-6">
        <title>Screening of designed siRNAs</title>
        <p>Each designed siRNA was screened based on thermodynamic evaluation of RNA-RNA interaction using the online bioinformatic software BIBISERV2-RNAHYBRID  <xref ref-type="bibr" rid="ref22">Rehmsmeier et al., 2004</xref>. Thermodynamic interaction was studied between predicted siRNA (guide strand) and target gene. A dynamic programming algorithm in the software was used to calculate the hybridization energy and base pairing form of two RNA sequences. The software also provides the hybridization structure for further evaluation. A flow chart representing the complete methodology used for screening of effective siRNA molecules against TRPC5 mRNA is illustrated in <xref ref-type="fig" rid="fig1"> Figure 1 </xref>.</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <caption>
            <p>Diagrammatic representation of complete methodology to evaluate potential siRNA against TRPC5 mRNA</p>
          </caption>
          <graphic xlink:href="bmrat.v5i1.405/fig1.png"/>
        </fig>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <p>According to siRNA tool results, three siRNAs have been designed from target mRNA sequences (<xref ref-type="fig" rid="tab1"> Table 1 </xref>; <xref ref-type="fig" rid="tab2"> Table 2 </xref>). The tool predicts the target sites from mRNA sequences for siRNA design. siRNA1 was designed from target sequence GTCAACTACTCACCGTACAGA at a site starting at the 25th position on the mRNA. The guide strand of the siRNA1 has a sequence complementary to the target site sequence (CAGUUGAUGAGUGGCAUGUCU). Similarly, siRNA 2 and siRNA 3 have target sequences GATGGACACGCAGTTCTCTGA and GAATTCACACCGGACATCACT, respectively, at sites starting at the 393th and 412th position on mRNA, respectively. The guide strands of siRNA 2 and siRNA 3 have the sequence CUACCUGUGCGUCAAGAGACU and CUUAAGUGUGGCCUGUAGUGA. Multiple sequence alignments showed the presence of a conserved region among the functional siRNAs.</p>
      <fig id="tab1">
        <label>Table 1</label>
        <caption>
          <p>InvivoGen cDNA prediction of siRNA</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/tab1.png"/>
      </fig>
      <fig id="tab2">
        <label>Table 2</label>
        <caption>
          <p>Manual formulation of siRNA by complementary base pair rule</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/tab2.png"/>
      </fig>
      <p><xref ref-type="fig" rid="fig2"> Figure 2 </xref> represent the phylogenetic relationship between the designed siRNAs. The branch length of the siRNA1, siRNA2 and siRNA3 are 0.311129, 1.75 and 0.311129, respectively. Their sequence similarity was evaluated using percent identity matrix (<xref ref-type="fig" rid="tab4"> Table 4 </xref>). siRNA 2 shows 36.84% and 33.33% similarity to siRNA 1 and siRNA 3, respectively. siRNA 1 is similar to siRNA 2 and siRNA 3 with 36.84% and 61.11% similarity, respectively. Additionally, siRNA 3 is similar to siRNA 1 and siRNA 2 with 33.33% and 61.11% similarity, respectively.</p>
      <fig id="fig2">
        <label>Figure 2</label>
        <caption>
          <p>Phylogenetic analysis of the designed siRNA molecules</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/fig2.png"/>
      </fig>
      <fig id="tab4">
        <label>Table 4</label>
        <caption>
          <p>Percentage identity matrix of the siRNA molecules after multiple sequence alignment</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/tab4.png"/>
      </fig>
      <p>The gene silencing efficacy of siRNA was evaluated based on the thermodynamic interaction between the target TRPC5 mRNA and the designed guide strands of siRNA. The minimum free energy of hybridization of the three designed siRNAs (e.g. siRNA1, siRNA2 and siRNA3) were as follows: -28.2 kcal/mol, -24.1 kcal/mol and -25.6 kcal/mol. Their corresponding GC content for each was 47.62%, 52.38% and 47.62%, respectively (<xref ref-type="fig" rid="tab3"> Table 3 </xref>). The hybridization structure was observed to evaluate further parameters such as linearity (<xref ref-type="fig" rid="fig3"> Figure 3 </xref>). From all these, sequence #1 (i.e. siRNA1) is a more suitable and accessible one since it has the least minimum free hybridization energy (-28.2 kcal/mol). Indeed, it is predicted to be the most efficient method towards TRPC5 gene silencing.</p>
      <fig id="tab3">
        <label>Table 3</label>
        <caption>
          <p>Design of siRNA molecules along with their corresponding free hybridization energy</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/tab3.png"/>
      </fig>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>This study was conducted with retrieval of TRPC5 mRNA sequence from NCBI. siRNA wizard tool has been used to identify potential, target specific siRNA molecules (from target mRNAs) that significantly reduces off-target silencing. The tool utilizes selection criteria for designing potential siRNA such as thermodynamics, GC content analysis, BLAST search, secondary structure avoidance, termination signal, and immunostimulatory motif exclusion (http://www.invivogen.com/sirna-wizard)</p>
      <p>All the 3 siRNA sequences were designed specifically to have low off target similarity which can be suitable for effective post-transcriptional gene silencing process. Multiple sequence alignment (via ClustalW tool) was used to check the sequence similarity across the siRNAs. A phylogenetic tree was constructed to study the evolutionary relationship and the consensus sequence between the designed functional low off target siRNA molecules. The analysis revealed the percentage similarity between the sequences with branch length shown in <xref ref-type="fig" rid="fig2"> Figure 2 </xref>.</p>
      <p>Gene silencing efficiency was assessed based on thermodynamic RNA-RNA interaction between siRNA (guide strand) and mRNA (target gene) using minimum free energy of hybridization. Secondary structure prediction of mRNA-siRNA complex is crucial for effective RNAi using minimum free energy as a target of structural accuracy <xref ref-type="bibr" rid="ref5">Bret et al., 2005</xref><xref ref-type="bibr" rid="ref18"> Mathews 2005</xref>. The free energy hybridization of the siRNA was calculated using the online server BIBISERV2-RNAHYBRID <xref ref-type="bibr" rid="ref29">Tuschl et al., 2002</xref>. This tool follows a dynamic programming algorithm for RNA secondary structure prediction. The secondary structure of the 3 designed siRNAs along with the target mRNAs are depicted in <xref ref-type="fig" rid="fig3"> Figure 3 </xref>.</p>
      <fig id="fig3">
        <label>Figure 3</label>
        <caption>
          <p>Predicted secondary structure of minimum free energy of hybridization between target TRPC5 mRNA and a) siRNA1, b) SiRNA2, c) siRNA3.</p>
        </caption>
        <graphic xlink:href="bmrat.v5i1.405/fig3.png"/>
      </fig>
      <p>The hybridization structure is used for further evaluation of various factors such as linearity of the mRNA-siRNA hybrid and GC content of siRNA. The linearity of the structure was evaluated based on the nucleotide in the loop structure region. The number of nucleotides in the loop region was inversely proportional to free energy and RNAi activity. The GC content of a siRNA is one of the essential parameters that might correlate with siRNA functionality. There is a negative correlation between target site accessibility and GC content. It is preferable to pick siRNAs with low GC content. Indeed, the GC content of the 3 siRNAs was in the range of 47-52%. The efficiency of silencing also depends on low GC content of siRNA. The best fitted siRNA (siRNA1) had 47.62% GC content. Thus, GC content is inversely proportional to RNAi mechanism <xref ref-type="bibr" rid="ref1">Amarzguioui et al., 2004</xref><xref ref-type="bibr" rid="ref23">Reynolds et al., 2004</xref>.</p>
      <p>In present study, three potential siRNA molecules were designed for silencing target TRPC5 mRNA. The best fitted siRNA was found to be siRNA1; it fulfilled all the necessary parameters, therefore supporting more effective binding of siRNA with target mRNA. Even though RNAi uses double stranded RNA in the form of siRNA or miRNA, siRNA is relatively superior than miRNA. This is due to the sequence specificity of siRNA and its delivery mechanism into the cell. siRNA mediated therapeutics have been efficient against metabolic disorders of liver and hypercholesterolemia in other studies <xref ref-type="bibr" rid="ref7">Czech et al., 2011</xref>. Hence, RNAi may have great potential for treatment of challenging or incurable conditions (e.g. glomerular filtration malfunction).</p>
    </sec>
    <sec id="s5">
      <title>Conclusion</title>
      <p>RNAi technology is the leading strategy and therapy for various incurable diseases and genetic disorders. The compatibility of siRNA with the target gene can be assessed using bioinformatics tools. In this study, siRNA1 had the least minimum free energy of hybridization (i.e. -28.2 kcal/mol), low GC content of 47.62%, and high linearity with minimal h-b index and loop structure. It is predicted to be the most efficient towards the TRPC5 gene silencing. Hence, siRNAs can be used as a therapeutic drug to act as an important inhibitor to suppress gene expression. Thus, siRNAs represent a potentially effective therapeutic strategy for treating glomerular filtration malfunction. Further in vivo investigations are warranted to confirm their efficacy.</p>
    </sec>
    <sec id="s6">
      <title>Author Contribution</title>
      <p>All authors were equally contributed to the study design, bioinformatics analysis, drafting of the manuscript and approved the manuscript for publication.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.</surname>
              <given-names>Amarzguioui</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Prydz</given-names>
            </name>
          </person-group>
          <article-title>An algorithm for selection of functional siRNA sequences</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <year>2004</year>
          <volume>316(4)</volume>
          <fpage>1050</fpage>
          <lpage>1058</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.02.157PMID:15044091</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>N. S.</surname>
              <given-names>Anavekar</given-names>
            </name>
            <name>
              <surname>D. J.</surname>
              <given-names>Gans</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Berl</given-names>
            </name>
            <name>
              <surname>R. D.</surname>
              <given-names>Rohde</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Cooper</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Bhaumik</given-names>
            </name>
            <name>
              <surname>M. A.</surname>
              <given-names>Pfeffer</given-names>
            </name>
          </person-group>
          <article-title>Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria</article-title>
          <source>Kidney International. Supplement</source>
          <year>2004</year>
          <volume>92(92)</volume>
          <fpage>S50</fpage>
          <lpage>S55</lpage>
        </element-citation>
      </ref>
      <ref id="ref3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>E.</surname>
              <given-names>Bernstein</given-names>
            </name>
            <name>
              <surname>A. A.</surname>
              <given-names>Caudy</given-names>
            </name>
            <name>
              <surname>S. M.</surname>
              <given-names>Hammond</given-names>
            </name>
            <name>
              <surname>G. J.</surname>
              <given-names>Hannon</given-names>
            </name>
          </person-group>
          <article-title>Role for a bidentate ribonuclease in the initiation step of RNA interference</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>409(6818)</volume>
          <fpage>363</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="doi">10.1038/35053110</pub-id>
          <pub-id pub-id-type="pmid">11201747</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G.</surname>
              <given-names>Berrut</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Bouhanick</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Fabbri</given-names>
            </name>
            <name>
              <surname>G.</surname>
              <given-names>Guilloteau</given-names>
            </name>
            <name>
              <surname>F.</surname>
              <given-names>Bled</given-names>
            </name>
            <name>
              <surname>J. J.</surname>
              <given-names>Le Jeune</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Marre</given-names>
            </name>
          </person-group>
          <article-title>Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension</article-title>
          <source>Clinical Nephrology</source>
          <year>1997</year>
          <volume>48(2)</volume>
          <fpage>92</fpage>
          <lpage>9</lpage>
	  <pub-id pub-id-type="pmid">9285145</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>SE</surname>
              <given-names>Bret</given-names>
            </name>
            <name>
              <surname>Soifer</surname>
              <given-names>Harris S.</given-names>
            </name>
            <name>
              <surname>Bowers</surname>
              <given-names>Chauncey</given-names>
            </name>
            <name>
              <surname>J. Rossi.</surname>
              <given-names>John</given-names>
            </name>
          </person-group>
          <article-title>siRNA target site secondary structure predictions using local stable substructures</article-title>
          <source>Nucleic Acid Res</source>
          <year>2005</year>
          <volume>33(3)</volume>
          <fpage>e30</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/gni026</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T. R.</surname>
              <given-names>Brummelkamp</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Bernards</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Agami</given-names>
            </name>
          </person-group>
          <article-title>A system for stable expression of short interfering RNAs in mammalian cells</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>296(5567)</volume>
          <fpage>550</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1068999</pub-id>
          <pub-id pub-id-type="pmid">11910072</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M. P.</surname>
              <given-names>Czech</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Aouadi</given-names>
            </name>
            <name>
              <surname>G. J.</surname>
              <given-names>Tesz</given-names>
            </name>
          </person-group>
          <article-title>RNAi-based therapeutic strategies for metabolic disease</article-title>
          <source>Nature Reviews. Endocrinology</source>
          <year>2011</year>
          <volume>7(8)</volume>
          <fpage>473</fpage>
          <lpage>484</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S. M.</surname>
              <given-names>Elbashir</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Lendeckel</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Tuschl</given-names>
            </name>
          </person-group>
          <article-title>RNA interference is mediated by 21- and 22-nucleotide RNAs</article-title>
          <source>Genes &amp; Development</source>
          <year>2001</year>
          <volume>15(2)</volume>
          <fpage>188</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.862301</pub-id>
          <pub-id pub-id-type="pmid">11157775</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M. G.</surname>
              <given-names>Farquhar</given-names>
            </name>
          </person-group>
          <article-title>The glomerular basement membrane: Not gone, just forgotten</article-title>
          <source>The Journal of Clinical Investigation</source>
          <year>2006</year>
          <volume>116(8)</volume>
          <fpage>2090</fpage>
          <lpage>2093</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI29488</pub-id>
          <pub-id pub-id-type="pmid">16886057</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.</surname>
              <given-names>Faul</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Donnelly</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Merscher-Gomez</given-names>
            </name>
            <name>
              <surname>Y. H.</surname>
              <given-names>Chang</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Franz</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Delfgaauw</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Mundel</given-names>
            </name>
          </person-group>
          <article-title>The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A</article-title>
          <source>Nature Medicine</source>
          <year>2008</year>
          <volume>14(9)</volume>
          <fpage>931</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.1857</pub-id>
          <pub-id pub-id-type="pmid">18724379</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H. C.</surname>
              <given-names>Gerstein</given-names>
            </name>
            <name>
              <surname>J. F.</surname>
              <given-names>Mann</given-names>
            </name>
            <name>
              <surname>Q.</surname>
              <given-names>Yi</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Zinman</given-names>
            </name>
            <name>
              <surname>S. F.</surname>
              <given-names>Dinneen</given-names>
            </name>
            <name>
              <surname>B.</surname>
              <given-names>Hoogwerf</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Yusuf</given-names>
            </name>
            <name name-style="given-only">
              <given-names>the HOPE Study Investigators</given-names>
            </name>
          </person-group>
          <article-title>Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals</article-title>
          <source>Journal of the American Medical Association</source>
          <year>2001</year>
          <volume>286(4)</volume>
          <fpage>421</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.286.4.421</pub-id>
          <pub-id pub-id-type="pmid">11466120</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S. M.</surname>
              <given-names>Hammond</given-names>
            </name>
            <name>
              <surname>E.</surname>
              <given-names>Bernstein</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Beach</given-names>
            </name>
            <name>
              <surname>G. J.</surname>
              <given-names>Hannon</given-names>
            </name>
          </person-group>
          <article-title>An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>404(6775)</volume>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1038/35005107</pub-id>
          <pub-id pub-id-type="pmid">10749213</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>B.</surname>
              <given-names>Haraldsson</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Nystr&#246;m</given-names>
            </name>
            <name>
              <surname>W. M.</surname>
              <given-names>Deen</given-names>
            </name>
          </person-group>
          <article-title>Properties of the glomerular barrier and mechanisms of proteinuria</article-title>
          <source>Physiological Reviews</source>
          <year>2008</year>
          <volume>88(2)</volume>
          <fpage>451</fpage>
          <lpage>487</lpage>
          <pub-id pub-id-type="doi">10.1152/physrev.00055.2006</pub-id>
          <pub-id pub-id-type="pmid">18391170</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A. L.</surname>
              <given-names>Jackson</given-names>
            </name>
            <name>
              <surname>P. S.</surname>
              <given-names>Linsley</given-names>
            </name>
          </person-group>
          <article-title>Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application</article-title>
          <source>Nature Reviews. Drug Discovery</source>
          <year>2010</year>
          <volume>9(1)</volume>
          <fpage>57</fpage>
          <lpage>67</lpage>
        </element-citation>
      </ref>
      <ref id="ref15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>W. F.</surname>
              <given-names>Keane</given-names>
            </name>
            <name>
              <surname>B. M.</surname>
              <given-names>Brenner</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>de Zeeuw</given-names>
            </name>
            <name>
              <surname>J. P.</surname>
              <given-names>Grunfeld</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>McGill</given-names>
            </name>
            <name>
              <surname>W. E.</surname>
              <given-names>Mitch</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Toto</given-names>
            </name>
            <name name-style="given-only">
              <given-names>the RENAAL Study Investigators.</given-names>
            </name>
          </person-group>
          <article-title>The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study</article-title>
          <source>Kidney International</source>
          <year>2003</year>
          <volume>63(4)</volume>
          <fpage>1499</fpage>
          <lpage>1507</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00885.x</pub-id>
          <pub-id pub-id-type="pmid">12631367</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>H.</surname>
              <given-names>Ma</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Togawa</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Soda</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Zhang</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Lee</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Ma</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Ishibe</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of podocyte FAK protects against proteinuria and foot process effacement</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <year>2010</year>
          <volume>21(7)</volume>
          <fpage>1145</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2009090991</pub-id>
          <pub-id pub-id-type="pmid">20522532</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Y.</surname>
              <given-names>Ma</given-names>
            </name>
            <name>
              <surname>C. Y.</surname>
              <given-names>Chan</given-names>
            </name>
            <name>
              <surname>M. L.</surname>
              <given-names>He</given-names>
            </name>
          </person-group>
          <article-title>RNA interference and antiviral therapy</article-title>
          <source>World Journal of Gastroenterology</source>
          <year>2007</year>
          <volume>13(39)</volume>
          <fpage>5169</fpage>
          <lpage>5179</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v13.i39.5169</pub-id>
          <pub-id pub-id-type="pmid">17876887</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D. H.</surname>
              <given-names>Mathews</given-names>
            </name>
          </person-group>
          <article-title>Predicting a set of minimal free energy RNA secondary structures common to two sequences</article-title>
          <source>Bioinformatics (Oxford</source>
          <year>2005</year>
          <volume>England)</volume>
          <fpage>21(10)</fpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bti349</pub-id>
          <pub-id pub-id-type="pmid">15731207</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C. E.</surname>
              <given-names>Mogensen</given-names>
            </name>
          </person-group>
          <article-title>Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes</article-title>
          <source>The New England Journal of Medicine</source>
          <year>1984</year>
          <volume>310(6)</volume>
          <fpage>356</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM198402093100605</pub-id>
          <pub-id pub-id-type="pmid">6690964</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C.</surname>
              <given-names>Montell</given-names>
            </name>
          </person-group>
          <article-title>TRP channels in Drosophila photoreceptor cells</article-title>
          <source>The Journal of Physiology</source>
          <year>2005</year>
          <volume>567(Pt 1)</volume>
          <fpage>45</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2005.092551</pub-id>
          <pub-id pub-id-type="pmid">15961416</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>I. S.</surname>
              <given-names>Ramsey</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Delling</given-names>
            </name>
            <name>
              <surname>D. E.</surname>
              <given-names>Clapham</given-names>
            </name>
          </person-group>
          <article-title>An introduction to TRP channels</article-title>
          <source>Annual Review of Physiology</source>
          <year>2006</year>
          <volume>68(1)</volume>
          <fpage>619</fpage>
          <lpage>647</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.physiol.68.040204.100431</pub-id>
          <pub-id pub-id-type="pmid">16460286</pub-id>
        </element-citation>
      </ref>
      <ref id="ref22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M.</surname>
              <given-names>Rehmsmeier</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Steffen</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Hochsmann</given-names>
            </name>
            <name>
              <surname>R.</surname>
              <given-names>Giegerich</given-names>
            </name>
          </person-group>
          <article-title>Fast and effective prediction of microRNA/target duplexes</article-title>
          <source>RNA (New York, N.Y.)</source>
          <year>2004</year>
          <volume>10(10)</volume>
          <fpage>1507</fpage>
          <lpage>1517</lpage>
        </element-citation>
      </ref>
      <ref id="ref23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.</surname>
              <given-names>Reynolds</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Leake</given-names>
            </name>
            <name>
              <surname>Q.</surname>
              <given-names>Boese</given-names>
            </name>
            <name>
              <surname>S.</surname>
              <given-names>Scaringe</given-names>
            </name>
            <name>
              <surname>W. S.</surname>
              <given-names>Marshall</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Khvorova</given-names>
            </name>
          </person-group>
          <article-title>Rational siRNA design for RNA interference</article-title>
          <source>Nature Biotechnology</source>
          <year>2004</year>
          <volume>22(3)</volume>
          <fpage>326</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt936</pub-id>
          <pub-id pub-id-type="pmid">14758366</pub-id>
        </element-citation>
      </ref>
      <ref id="ref24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.</surname>
              <given-names>Riccio</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Moon</given-names>
            </name>
            <name>
              <surname>K. S.</surname>
              <given-names>Kim</given-names>
            </name>
            <name>
              <surname>K. S.</surname>
              <given-names>Smith</given-names>
            </name>
            <name>
              <surname>U.</surname>
              <given-names>Rudolph</given-names>
            </name>
            <name>
              <surname>D. E.</surname>
              <given-names>Clapham</given-names>
            </name>
          </person-group>
          <article-title>Essential role for TRPC5 in amygdala function and fear-related behavior</article-title>
          <source>Cell</source>
          <year>2009</year>
          <volume>137(4)</volume>
          <fpage>761</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2009.03.039</pub-id>
          <pub-id pub-id-type="pmid">19450521</pub-id>
        </element-citation>
      </ref>
      <ref id="ref25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S. M.</surname>
              <given-names>Elbashir</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Harborth</given-names>
            </name>
            <name>
              <surname>W.</surname>
              <given-names>Lendeckel</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Yalcin</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Weber</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Tuschl</given-names>
            </name>
          </person-group>
          <article-title>Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>411(6836)</volume>
          <fpage>494</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1038/35078107</pub-id>
          <pub-id pub-id-type="pmid">11373684</pub-id>
        </element-citation>
      </ref>
      <ref id="ref26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>schaldecker</surname>
              <given-names>Thomas</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Sookyung</given-names>
            </name>
            <name>
              <surname>Tarabanis</surname>
              <given-names>Constantine</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Dequan</given-names>
            </name>
            <name>
              <surname>Hakroush</surname>
              <given-names>Samy</given-names>
            </name>
            <name>
              <surname>Castonguay</surname>
              <given-names>Philip</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>Wooin</given-names>
            </name>
            <name>
              <surname>Wallentin</surname>
              <given-names>Hanna</given-names>
            </name>
            <name>
              <surname>Heid</surname>
              <given-names>Hans</given-names>
            </name>
            <name>
              <surname>R. Hopkins</surname>
              <given-names>Corey</given-names>
            </name>
            <name>
              <surname>W. Lindsley</surname>
              <given-names>Craig</given-names>
            </name>
            <name>
              <surname>Riccio</surname>
              <given-names>Antonio</given-names>
            </name>
            <name>
              <surname>Buvall</surname>
              <given-names>Lisa</given-names>
            </name>
            <name>
              <surname>Weins</surname>
              <given-names>Astrid</given-names>
            </name>
            <name>
              <surname>Greka</surname>
              <given-names>Anna</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of the TRPC5 ion channel protects the kidney filter</article-title>
          <source>J Clin Invest</source>
          <year>2013</year>
          <volume>123(12)</volume>
          <fpage>5298</fpage>
          <lpage>5309</lpage>
        </element-citation>
      </ref>
      <ref id="ref27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D.</surname>
              <given-names>Tian</given-names>
            </name>
            <name>
              <surname>S. M.</surname>
              <given-names>Jacobo</given-names>
            </name>
            <name>
              <surname>D.</surname>
              <given-names>Billing</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Rozkalne</given-names>
            </name>
            <name>
              <surname>S. D.</surname>
              <given-names>Gage</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Anagnostou</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Greka</given-names>
            </name>
          </person-group>
          <article-title>Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels</article-title>
          <source>Science Signaling</source>
          <year>2010</year>
          <volume>3(145)</volume>
          <fpage>ra77</fpage>
          <pub-id pub-id-type="doi">10.1126/scisignal.2001200</pub-id>
          <pub-id pub-id-type="pmid">20978238</pub-id>
        </element-citation>
      </ref>
      <ref id="ref28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>A.</surname>
              <given-names>Togawa</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Miyoshi</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Ishizaki</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Tanaka</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Takakura</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Nishioka</given-names>
            </name>
            <name>
              <surname>Y.</surname>
              <given-names>Takai</given-names>
            </name>
          </person-group>
          <article-title>Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha</article-title>
          <source>Oncogene</source>
          <year>1999</year>
          <volume>18(39)</volume>
          <fpage>5373</fpage>
          <lpage>5380</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1202921</pub-id>
          <pub-id pub-id-type="pmid">10498891</pub-id>
        </element-citation>
      </ref>
      <ref id="ref29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>T.</surname>
              <given-names>Tuschl</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Borkhardt</given-names>
            </name>
          </person-group>
          <article-title>Small interfering RNAs: Arevolutionary tool for the analysis of genefunction and genetherapy</article-title>
          <source>Molecular Interventions</source>
          <year>2002</year>
          <volume>2(3)</volume>
          <fpage>158</fpage>
          <lpage>167.</lpage>
          <pub-id pub-id-type="doi">10.1124/mi.2.3.158</pub-id>
          <pub-id pub-id-type="pmid">14993376</pub-id>
        </element-citation>
      </ref>
      <ref id="ref30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S. Z.</surname>
              <given-names>Xu</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Sukumar</given-names>
            </name>
            <name>
              <surname>F.</surname>
              <given-names>Zeng</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Li</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>Jairaman</given-names>
            </name>
            <name>
              <surname>A.</surname>
              <given-names>English</given-names>
            </name>
            <name>
              <surname>D. J.</surname>
              <given-names>Beech</given-names>
            </name>
          </person-group>
          <article-title>TRPC channel activation by extracellular thioredoxin</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>451(7174)</volume>
          <fpage>69</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1038/nature06414</pub-id>
          <pub-id pub-id-type="pmid">18172497</pub-id>
        </element-citation>
      </ref>
      <ref id="ref31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>E.</surname>
              <given-names>Yanagida-Asanuma</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Asanuma</given-names>
            </name>
            <name>
              <surname>K.</surname>
              <given-names>Kim</given-names>
            </name>
            <name>
              <surname>M.</surname>
              <given-names>Donnelly</given-names>
            </name>
            <name>
              <surname>H.</surname>
              <given-names>Young Choi</given-names>
            </name>
            <name>
              <surname>J.</surname>
              <given-names>Hyung Chang</given-names>
            </name>
            <name>
              <surname>P.</surname>
              <given-names>Mundel</given-names>
            </name>
          </person-group>
          <article-title>Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes</article-title>
          <source>American Journal of Pathology</source>
          <year>2007</year>
          <volume>171(2)</volume>
          <fpage>415</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="doi">10.2353/ajpath.2007.070075</pub-id>
          <pub-id pub-id-type="pmid">17569780</pub-id>
        </element-citation>
      </ref>
      <ref id="ref32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>P.D.</surname>
              <given-names>Zamore</given-names>
            </name>
            <name>
              <surname>T.</surname>
              <given-names>Tuschl</given-names>
            </name>
            <name>
              <surname>P.A.</surname>
              <given-names>Sharp</given-names>
            </name>
            <name>
              <surname>D.P.</surname>
              <given-names>Bartel</given-names>
            </name>
          </person-group>
          <article-title>RNAi:Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals</article-title>
          <source>Cell</source>
          <year>2000</year>
          <volume>101(1)</volume>
          <fpage>25</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80620-0</pub-id>
	  <pub-id pub-id-type="pmid">10778853</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
